GLP-1 medications likeSemaglutideandTirzepatidehelp balance appetite, blood sugar, and energy for steady, sustainable fat loss
Lost 47 pounds in 10 months and it's stayed off
Secondly, GLP-1 receptor agonists carry important safety considerations including risk of pancreatitis, gallbladder disease, and potential thyroid C-cell tumours (based on rodent studies, though human relevance remains uncertain)
Because these procedures permanently change digestion, bariatric patients usually require lifelong attention to protein intake, hydration, supplementation, and structured eating habits
Coverage restrictions and high out-of-pocket costs
GLP-1 also inhibits the production of glucagon from the pancreas